Acelyrin's headquarters in Agoura Hills. (courtesy photo) Shares of Conejo Valley-based Acelyrin have been dropping ever since the company went public over a year ago in May 2023, but recent changes could be hoping to turn that around. Acelyrin, which has major backing from Westlake Village BioPartners, announced in May, right before the company's first-quarter earnings for…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
